img

Global Atovaquone Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Atovaquone Market Insights, Forecast to 2034

Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.
Global Atovaquone market is expected to reach to US$ 197 million in 2024, with a positive growth of %, compared with US$ 185 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Atovaquone industry is evaluated to reach US$ 282.6 million in 2029. The CAGR will be 6.2% during 2024 to 2029.
Globally, Atovaquone key manufacturers include GSK, Lupin, Apotex and Amneal Pharmaceuticals, etc. GSK, Lupin, Apotex are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Atovaquone were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Atovaquone market and estimated to attract more attentions from industry insiders and investors.
Atovaquone can be divided into 250mg and 500mg, etc. 250mg is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Atovaquone is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Atovaquone industry development. In 2022, global % sales of Atovaquone went into Hospital filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Atovaquone market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Atovaquone market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Lupin
Apotex
Amneal Pharmaceuticals
Segment by Type
250mg
500mg

Segment by Application


Hospital
Drug Store

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Atovaquone plant distribution, commercial date of Atovaquone, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Atovaquone introduction, etc. Atovaquone Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Atovaquone
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Atovaquone Product Introduction
1.2 Market by Type
1.2.1 Global Atovaquone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 250mg
1.2.3 500mg
1.3 Market by Application
1.3.1 Global Atovaquone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Atovaquone Sales Estimates and Forecasts 2018-2029
2.2 Global Atovaquone Revenue by Region
2.2.1 Global Atovaquone Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Atovaquone Revenue by Region (2018-2024)
2.2.3 Global Atovaquone Revenue by Region (2024-2029)
2.2.4 Global Atovaquone Revenue Market Share by Region (2018-2029)
2.3 Global Atovaquone Sales Estimates and Forecasts 2018-2029
2.4 Global Atovaquone Sales by Region
2.4.1 Global Atovaquone Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Atovaquone Sales by Region (2018-2024)
2.4.3 Global Atovaquone Sales by Region (2024-2029)
2.4.4 Global Atovaquone Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Atovaquone Sales by Manufacturers
3.1.1 Global Atovaquone Sales by Manufacturers (2018-2024)
3.1.2 Global Atovaquone Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atovaquone in 2022
3.2 Global Atovaquone Revenue by Manufacturers
3.2.1 Global Atovaquone Revenue by Manufacturers (2018-2024)
3.2.2 Global Atovaquone Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Atovaquone Revenue in 2022
3.3 Global Key Players of Atovaquone, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Atovaquone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Atovaquone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Atovaquone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Atovaquone, Product Offered and Application
3.8 Global Key Manufacturers of Atovaquone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Atovaquone Sales by Type
4.1.1 Global Atovaquone Historical Sales by Type (2018-2024)
4.1.2 Global Atovaquone Forecasted Sales by Type (2024-2029)
4.1.3 Global Atovaquone Sales Market Share by Type (2018-2029)
4.2 Global Atovaquone Revenue by Type
4.2.1 Global Atovaquone Historical Revenue by Type (2018-2024)
4.2.2 Global Atovaquone Forecasted Revenue by Type (2024-2029)
4.2.3 Global Atovaquone Revenue Market Share by Type (2018-2029)
4.3 Global Atovaquone Price by Type
4.3.1 Global Atovaquone Price by Type (2018-2024)
4.3.2 Global Atovaquone Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Atovaquone Sales by Application
5.1.1 Global Atovaquone Historical Sales by Application (2018-2024)
5.1.2 Global Atovaquone Forecasted Sales by Application (2024-2029)
5.1.3 Global Atovaquone Sales Market Share by Application (2018-2029)
5.2 Global Atovaquone Revenue by Application
5.2.1 Global Atovaquone Historical Revenue by Application (2018-2024)
5.2.2 Global Atovaquone Forecasted Revenue by Application (2024-2029)
5.2.3 Global Atovaquone Revenue Market Share by Application (2018-2029)
5.3 Global Atovaquone Price by Application
5.3.1 Global Atovaquone Price by Application (2018-2024)
5.3.2 Global Atovaquone Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Atovaquone Market Size by Type
6.1.1 US & Canada Atovaquone Sales by Type (2018-2029)
6.1.2 US & Canada Atovaquone Revenue by Type (2018-2029)
6.2 US & Canada Atovaquone Market Size by Application
6.2.1 US & Canada Atovaquone Sales by Application (2018-2029)
6.2.2 US & Canada Atovaquone Revenue by Application (2018-2029)
6.3 US & Canada Atovaquone Market Size by Country
6.3.1 US & Canada Atovaquone Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Atovaquone Sales by Country (2018-2029)
6.3.3 US & Canada Atovaquone Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Atovaquone Market Size by Type
7.1.1 Europe Atovaquone Sales by Type (2018-2029)
7.1.2 Europe Atovaquone Revenue by Type (2018-2029)
7.2 Europe Atovaquone Market Size by Application
7.2.1 Europe Atovaquone Sales by Application (2018-2029)
7.2.2 Europe Atovaquone Revenue by Application (2018-2029)
7.3 Europe Atovaquone Market Size by Country
7.3.1 Europe Atovaquone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Atovaquone Sales by Country (2018-2029)
7.3.3 Europe Atovaquone Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Atovaquone Market Size
8.1.1 China Atovaquone Sales (2018-2029)
8.1.2 China Atovaquone Revenue (2018-2029)
8.2 China Atovaquone Market Size by Application
8.2.1 China Atovaquone Sales by Application (2018-2029)
8.2.2 China Atovaquone Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Atovaquone Market Size by Type
9.1.1 Asia Atovaquone Sales by Type (2018-2029)
9.1.2 Asia Atovaquone Revenue by Type (2018-2029)
9.2 Asia Atovaquone Market Size by Application
9.2.1 Asia Atovaquone Sales by Application (2018-2029)
9.2.2 Asia Atovaquone Revenue by Application (2018-2029)
9.3 Asia Atovaquone Sales by Region
9.3.1 Asia Atovaquone Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Atovaquone Revenue by Region (2018-2029)
9.3.3 Asia Atovaquone Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Atovaquone Market Size by Type
10.1.1 Middle East, Africa and Latin America Atovaquone Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Atovaquone Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Atovaquone Market Size by Application
10.2.1 Middle East, Africa and Latin America Atovaquone Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Atovaquone Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Atovaquone Sales by Country
10.3.1 Middle East, Africa and Latin America Atovaquone Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Atovaquone Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Atovaquone Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Atovaquone Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 GSK Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Lupin
11.2.1 Lupin Company Information
11.2.2 Lupin Overview
11.2.3 Lupin Atovaquone Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Lupin Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Lupin Recent Developments
11.3 Apotex
11.3.1 Apotex Company Information
11.3.2 Apotex Overview
11.3.3 Apotex Atovaquone Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Apotex Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Apotex Recent Developments
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Information
11.4.2 Amneal Pharmaceuticals Overview
11.4.3 Amneal Pharmaceuticals Atovaquone Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Amneal Pharmaceuticals Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amneal Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Atovaquone Industry Chain Analysis
12.2 Atovaquone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Atovaquone Production Mode & Process
12.4 Atovaquone Sales and Marketing
12.4.1 Atovaquone Sales Channels
12.4.2 Atovaquone Distributors
12.5 Atovaquone Customers
13 Market Dynamics
13.1 Atovaquone Industry Trends
13.2 Atovaquone Market Drivers
13.3 Atovaquone Market Challenges
13.4 Atovaquone Market Restraints
14 Key Findings in The Global Atovaquone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Atovaquone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 250mg
Table 3. Major Manufacturers of 500mg
Table 4. Global Atovaquone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Atovaquone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Atovaquone Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Atovaquone Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Atovaquone Revenue Market Share by Region (2018-2024)
Table 9. Global Atovaquone Revenue Market Share by Region (2024-2029)
Table 10. Global Atovaquone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Atovaquone Sales by Region (2018-2024) & (K Units)
Table 12. Global Atovaquone Sales by Region (2024-2029) & (K Units)
Table 13. Global Atovaquone Sales Market Share by Region (2018-2024)
Table 14. Global Atovaquone Sales Market Share by Region (2024-2029)
Table 15. Global Atovaquone Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Atovaquone Sales Share by Manufacturers (2018-2024)
Table 17. Global Atovaquone Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Atovaquone Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Atovaquone, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Atovaquone Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Atovaquone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Atovaquone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atovaquone as of 2022)
Table 23. Global Key Manufacturers of Atovaquone, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Atovaquone, Product Offered and Application
Table 25. Global Key Manufacturers of Atovaquone, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Atovaquone Sales by Type (2018-2024) & (K Units)
Table 28. Global Atovaquone Sales by Type (2024-2029) & (K Units)
Table 29. Global Atovaquone Sales Share by Type (2018-2024)
Table 30. Global Atovaquone Sales Share by Type (2024-2029)
Table 31. Global Atovaquone Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Atovaquone Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Atovaquone Revenue Share by Type (2018-2024)
Table 34. Global Atovaquone Revenue Share by Type (2024-2029)
Table 35. Atovaquone Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Atovaquone Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Atovaquone Sales by Application (2018-2024) & (K Units)
Table 38. Global Atovaquone Sales by Application (2024-2029) & (K Units)
Table 39. Global Atovaquone Sales Share by Application (2018-2024)
Table 40. Global Atovaquone Sales Share by Application (2024-2029)
Table 41. Global Atovaquone Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Atovaquone Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Atovaquone Revenue Share by Application (2018-2024)
Table 44. Global Atovaquone Revenue Share by Application (2024-2029)
Table 45. Atovaquone Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Atovaquone Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Atovaquone Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Atovaquone Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Atovaquone Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Atovaquone Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Atovaquone Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Atovaquone Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Atovaquone Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Atovaquone Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Atovaquone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Atovaquone Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Atovaquone Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Atovaquone Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Atovaquone Sales by Country (2024-2029) & (K Units)
Table 60. Europe Atovaquone Sales by Type (2018-2024) & (K Units)
Table 61. Europe Atovaquone Sales by Type (2024-2029) & (K Units)
Table 62. Europe Atovaquone Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Atovaquone Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Atovaquone Sales by Application (2018-2024) & (K Units)
Table 65. Europe Atovaquone Sales by Application (2024-2029) & (K Units)
Table 66. Europe Atovaquone Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Atovaquone Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Atovaquone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Atovaquone Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Atovaquone Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Atovaquone Sales by Country (2018-2024) & (K Units)
Table 72. Europe Atovaquone Sales by Country (2024-2029) & (K Units)
Table 73. China Atovaquone Sales by Type (2018-2024) & (K Units)
Table 74. China Atovaquone Sales by Type (2024-2029) & (K Units)
Table 75. China Atovaquone Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Atovaquone Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Atovaquone Sales by Application (2018-2024) & (K Units)
Table 78. China Atovaquone Sales by Application (2024-2029) & (K Units)
Table 79. China Atovaquone Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Atovaquone Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Atovaquone Sales by Type (2018-2024) & (K Units)
Table 82. Asia Atovaquone Sales by Type (2024-2029) & (K Units)
Table 83. Asia Atovaquone Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Atovaquone Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Atovaquone Sales by Application (2018-2024) & (K Units)
Table 86. Asia Atovaquone Sales by Application (2024-2029) & (K Units)
Table 87. Asia Atovaquone Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Atovaquone Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Atovaquone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Atovaquone Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Atovaquone Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Atovaquone Sales by Region (2018-2024) & (K Units)
Table 93. Asia Atovaquone Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Atovaquone Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Atovaquone Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Atovaquone Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Atovaquone Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Atovaquone Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Atovaquone Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Atovaquone Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Atovaquone Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Atovaquone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Atovaquone Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Atovaquone Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Atovaquone Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Atovaquone Sales by Country (2024-2029) & (K Units)
Table 107. GSK Company Information
Table 108. GSK Description and Major Businesses
Table 109. GSK Atovaquone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. GSK Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GSK Recent Developments
Table 112. Lupin Company Information
Table 113. Lupin Description and Major Businesses
Table 114. Lupin Atovaquone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Lupin Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Lupin Recent Developments
Table 117. Apotex Company Information
Table 118. Apotex Description and Major Businesses
Table 119. Apotex Atovaquone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Apotex Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Apotex Recent Developments
Table 122. Amneal Pharmaceuticals Company Information
Table 123. Amneal Pharmaceuticals Description and Major Businesses
Table 124. Amneal Pharmaceuticals Atovaquone Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Amneal Pharmaceuticals Atovaquone Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Amneal Pharmaceuticals Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Atovaquone Distributors List
Table 130. Atovaquone Customers List
Table 131. Atovaquone Market Trends
Table 132. Atovaquone Market Drivers
Table 133. Atovaquone Market Challenges
Table 134. Atovaquone Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Atovaquone Product Picture
Figure 2. Global Atovaquone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Atovaquone Market Share by Type in 2022 & 2029
Figure 4. 250mg Product Picture
Figure 5. 500mg Product Picture
Figure 6. Global Atovaquone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Atovaquone Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Atovaquone Report Years Considered
Figure 11. Global Atovaquone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Atovaquone Revenue 2018-2029 (US$ Million)
Figure 13. Global Atovaquone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Atovaquone Revenue Market Share by Region (2018-2029)
Figure 15. Global Atovaquone Sales 2018-2029 ((K Units)
Figure 16. Global Atovaquone Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Atovaquone Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Atovaquone Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Atovaquone Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Atovaquone Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Atovaquone Sales YoY (2018-2029) & (K Units)
Figure 22. China Atovaquone Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Atovaquone Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Atovaquone Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Atovaquone Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Atovaquone Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Atovaquone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Atovaquone in the World: Market Share by Atovaquone Revenue in 2022
Figure 29. Global Atovaquone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Atovaquone Sales Market Share by Type (2018-2029)
Figure 31. Global Atovaquone Revenue Market Share by Type (2018-2029)
Figure 32. Global Atovaquone Sales Market Share by Application (2018-2029)
Figure 33. Global Atovaquone Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Atovaquone Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Atovaquone Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Atovaquone Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Atovaquone Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Atovaquone Revenue Share by Country (2018-2029)
Figure 39. US & Canada Atovaquone Sales Share by Country (2018-2029)
Figure 40. U.S. Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Atovaquone Sales Market Share by Type (2018-2029)
Figure 43. Europe Atovaquone Revenue Market Share by Type (2018-2029)
Figure 44. Europe Atovaquone Sales Market Share by Application (2018-2029)
Figure 45. Europe Atovaquone Revenue Market Share by Application (2018-2029)
Figure 46. Europe Atovaquone Revenue Share by Country (2018-2029)
Figure 47. Europe Atovaquone Sales Share by Country (2018-2029)
Figure 48. Germany Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 49. France Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 53. China Atovaquone Sales Market Share by Type (2018-2029)
Figure 54. China Atovaquone Revenue Market Share by Type (2018-2029)
Figure 55. China Atovaquone Sales Market Share by Application (2018-2029)
Figure 56. China Atovaquone Revenue Market Share by Application (2018-2029)
Figure 57. Asia Atovaquone Sales Market Share by Type (2018-2029)
Figure 58. Asia Atovaquone Revenue Market Share by Type (2018-2029)
Figure 59. Asia Atovaquone Sales Market Share by Application (2018-2029)
Figure 60. Asia Atovaquone Revenue Market Share by Application (2018-2029)
Figure 61. Asia Atovaquone Revenue Share by Region (2018-2029)
Figure 62. Asia Atovaquone Sales Share by Region (2018-2029)
Figure 63. Japan Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 67. India Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Atovaquone Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Atovaquone Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Atovaquone Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Atovaquone Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Atovaquone Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Atovaquone Sales Share by Country (2018-2029)
Figure 74. Brazil Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Atovaquone Revenue (2018-2029) & (US$ Million)
Figure 79. Atovaquone Value Chain
Figure 80. Atovaquone Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries